Key statistical concepts in clinical trials for pharma /
Saved in:
| Author / Creator: | Turner, J. Rick. |
|---|---|
| Imprint: | New York, NY : Springer, c2012. |
| Description: | 1 online resource (ix, 61 p.) |
| Language: | English |
| Series: | SpringerBriefs in pharmaceutical science & drug development, 1864-8118 SpringerBriefs in Pharmaceutical Science & Drug Development. |
| Subject: | Drug Evaluation. Clinical Trials as Topic. Data Interpretation, Statistical. Risk Assessment. Drug development. Drugs -- Testing. Drug development. Drugs -- Testing. Electronic books. |
| Format: | E-Resource Book |
| URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/8871588 |
| LEADER | 02333cam a2200541Ia 4500 | ||
|---|---|---|---|
| 001 | 8871588 | ||
| 003 | ICU | ||
| 005 | 20120827122200.0 | ||
| 006 | m d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 111026s2012 nyu ob 000 0 eng d | ||
| 020 | |a 9781461416623 (electronic bk.) | ||
| 020 | |a 1461416620 (electronic bk.) | ||
| 035 | |a (OCoLC)758652057 | ||
| 035 | |a (ICU)8871588 | ||
| 040 | |a GW5XE |c GW5XE |d E7B |d YDXCP |d CDX |d OHS | ||
| 049 | |a CGUA | ||
| 082 | 0 | 4 | |a 615.10724 |2 23 |
| 090 | |a RM301.27 |b .K49 2012 | ||
| 096 | |a QV 771 | ||
| 100 | 1 | |a Turner, J. Rick. |0 http://id.loc.gov/authorities/names/n92803816 |1 http://viaf.org/viaf/5003955 | |
| 245 | 1 | 0 | |a Key statistical concepts in clinical trials for pharma / |c J. Rick Turner. |
| 260 | |a New York, NY : |b Springer, |c c2012. | ||
| 300 | |a 1 online resource (ix, 61 p.) | ||
| 336 | |a text |b txt |2 rdacontent |0 http://id.loc.gov/vocabulary/contentTypes/txt | ||
| 337 | |a computer |b c |2 rdamedia |0 http://id.loc.gov/vocabulary/mediaTypes/c | ||
| 338 | |a online resource |b cr |2 rdacarrier |0 http://id.loc.gov/vocabulary/carriers/cr | ||
| 490 | 1 | |a SpringerBriefs in pharmaceutical science & drug development, |x 1864-8118 | |
| 504 | |a Includes bibliographical references. | ||
| 650 | 2 | |a Drug Evaluation. | |
| 650 | 2 | |a Clinical Trials as Topic. | |
| 650 | 2 | |a Data Interpretation, Statistical. | |
| 650 | 2 | |a Risk Assessment. | |
| 650 | 0 | |a Drug development. |0 http://id.loc.gov/authorities/subjects/sh97007921 | |
| 650 | 0 | |a Drugs |x Testing. |0 http://id.loc.gov/authorities/subjects/sh85039755 | |
| 650 | 7 | |a Drug development. |2 fast |0 http://id.worldcat.org/fast/fst00898670 | |
| 650 | 7 | |a Drugs |x Testing. |2 fast |0 http://id.worldcat.org/fast/fst00898940 | |
| 653 | 4 | |a Medicine | |
| 653 | 4 | |a Pharmaceutical technology | |
| 653 | 4 | |a Biomedicine | |
| 653 | 4 | |a Pharmaceutical Sciences/Technology | |
| 655 | 4 | |a Electronic books. | |
| 830 | 0 | |a SpringerBriefs in Pharmaceutical Science & Drug Development. | |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/978-1-4614-1662-3 |y SpringerLink |
| 903 | |a HeVa | ||
| 929 | |a eresource | ||
| 999 | f | f | |i 11c2f114-56ce-5b16-836f-c38997d62054 |s 7da29d74-8d99-51a4-8256-26d11a3f276a |
| 928 | |t Library of Congress classification |a RM301.27 .K49 2012 |l Online |c UC-FullText |u http://dx.doi.org/10.1007/978-1-4614-1662-3 |z SpringerLink |g ebooks |i 11485019 | ||